Changhoon Ji

Company: AUTOTAC Bio

Job title: Chief Technology Officer / Research Assistant Professor

Seminars:

Harnessing the AUTOTAC Platform for Development of a First-In-Class Tau Aggregate Degrader: Bridging the Gap Between Discovery, Preclinical Candidacy & Clinical Trials 9:00 am

Development of a novel targeted protein degradation platform (AUTOTAC) via p62-dependent selective macro-autophagy Application of the AUTOTAC platform to develop a first-in-class tau aggregate degrader ready for clinical trials Translation of academic discovery into industry-level drug developmentRead more

day: Conference Day One